Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies

• Type: Article in International Scientific Journal
• Date: 2011

Authors

Doktorovova, S (Author) Other; Shegokar, R (Author) Other; Rakovsky, E (Author) Other; Gonzalez Mira, E (Author) Other; Lopes, CM (Author) Other; Silva, AM (Author) Other; Martins Lopes, P (Author) Other; Muller, RH (Author) Other; Souto, EB (Author) Other

Journal

Title: International Journal of Pharmaceutics

Vol. 420

Pages: 341-349

ISSN: 0378-5173

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 35 Citations

Scopus - 55 Citations

Other information

Authenticus ID: P-002-JH7

DOI: 10.1016/j.ijpharm.2011.08.042

Abstract (EN): Cationic solid lipid nanoparticles (cSLN) are promising lipid nanocarriers for intracellular gene delivery based on well-known and widely accepted materials. cSLN containing single-chained cationic lipid cetyltrimethylammonium bromide were produced by high pressure homogenization and characterized in terms of (a) particle size distribution by photon correlation spectroscopy (PCS) and laser diffractometry (LD), (b) thermal behaviour using differential scanning calorimetry (DSC) and (c) the presence of various polymorphic phases was confirmed by X-ray diffraction (WAXD). SLN composed of Imwitor 900P (TM) (IMW) showed different pDNA stability and binding capacity in comparison to those of Compritol 888 ATO (TM) (COM). IMW-SLN, having z-ave = 138-157 nm and d(0.5) = 0.15-0.158 mu m could maintain this size for 14 days at room temperature. COM-SLN had z-ave = 334 nm and d(0.5)= 0.42 mu m on the day of production and could maintain similar size during 90 days. IMW-SLN revealed improved pDNA binding capacity. We attempted to explain these differences by different interactions between the solid lipid and the tested cationic lipid.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 9